glycine has been researched along with Chronic Disease in 89 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Latrunculin A microperfusion of the hippocampus induces acute epileptic seizures and long-term biochemical changes leading to spontaneous seizures." | 7.80 | Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014) |
| "This study investigated the value of morphine-augmentation in patients who demonstrated gallbladder nonvisualization with a pericholecystic rim sign at 1 hr, a cholescintigraphic pattern considered highly predictive of acute cholecystitis." | 7.69 | Gallbladder nonvisualization with pericholecystic rim sign: morphine-augmentation optimizes diagnosis of acute cholecystitis. ( Achong, DM; Chin, CT; Oates, E; Selland, DL, 1996) |
| "Ixazomib is an oral, second-generation, proteasome inhibitor that has been shown in preclinical models to prevent GVHD." | 6.94 | Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. ( Abedin, S; Chhabra, S; D'Souza, A; Dhakal, B; Douglas Rizzo, J; Drobyski, WR; Fenske, TS; Hamadani, M; Hari, PN; Horowitz, MM; Jerkins, JH; Pasquini, MC; Runaas, L; Saber, W; Shah, NN; Shaw, BE; Tang, X; Thompson, R; Visotcky, A; Zhang, MJ; Zhu, F, 2020) |
| "Tinnitus was induced in rats using unilateral, 1 h, 17 kHz-centered octave-band noise (116 dB SPL) and assessed using a gap-startle method." | 5.35 | Plasticity at glycinergic synapses in dorsal cochlear nucleus of rats with behavioral evidence of tinnitus. ( Brozoski, TJ; Caspary, DM; Hughes, LF; Ling, L; Parrish, JL; Turner, JG; Wang, H, 2009) |
| "Glycine (GLY), which acts as an obligatory co-agonist at the NMDAR-GLY site, induces PPI deficits in rats although, consistent with the hypo-NMDAR hypothesis, improves negative and cognitive symptoms in schizophrenia patients." | 5.34 | High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. ( Bar, G; Ebstein, RP; Ermilov, M; Heresco-Levy, U; Javitt, DC; Levin, R, 2007) |
| "Glycine was administered in an effort to facilitate endogenous glutamatergic transmission at the level of the N-methyl-D-aspartate (NMDA) receptor complex, since a glutamatergic deficiency in the pathophysiology of schizophrenia has been postulated." | 5.28 | Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study. ( Banay-Schwartz, M; Cohen, CG; Deutsch, SI; Leighton, M; Rosse, RB; Scarcella, E; Theut, SK, 1989) |
| "The purpose of this study is to explore depression metabolic markers in rat hippocampus and to investigate the anti-depressant effect of genipin and its mechanisms using nuclear magnetic resonance (NMR) metabonomics." | 3.80 | [1H NMR based metabonomics study on the antidepressant effect of genipin in rat hippocampus]. ( Gao, S; Peng, GJ; Qin, XM; Shi, BY; Tian, JS, 2014) |
| "Latrunculin A microperfusion of the hippocampus induces acute epileptic seizures and long-term biochemical changes leading to spontaneous seizures." | 3.80 | Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014) |
| "Isovaline reduced responses in mouse pain models without producing acute toxicity, possibly by enhancing receptor modulation of nociceptive information." | 3.76 | Analgesic properties of the novel amino acid, isovaline. ( Chung, CC; MacLeod, BA; Puil, E; Ries, CR; Schwarz, SK; Wang, JT, 2010) |
| "GABA and glycine are inhibitory neurotransmitters used by many neurons in the spinal dorsal horn, and intrathecal administration of GABA(A) and glycine receptor antagonists produces behavioural signs of allodynia, suggesting that these transmitters have an important role in spinal pain mechanisms." | 3.72 | Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain. ( Hughes, DI; Maxwell, DJ; Polgár, E; Puskár, Z; Riddell, JS; Todd, AJ, 2003) |
| " To substantiate the validity of this hypothesis we evaluated the renal response to glycine and the extent of glomerular damage 10-12 weeks after induction of anti-glomerular basement membrane glomerulonephritis with or without superimposed clip hypertension." | 3.69 | Renal functional reserve in experimental chronic glomerulonephritis. ( De Nicola, L; Gabbai, FB; Kaiser, JA; Obagi, S; Peterson, OW; Wilson, CB, 1994) |
| "This study investigated the value of morphine-augmentation in patients who demonstrated gallbladder nonvisualization with a pericholecystic rim sign at 1 hr, a cholescintigraphic pattern considered highly predictive of acute cholecystitis." | 3.69 | Gallbladder nonvisualization with pericholecystic rim sign: morphine-augmentation optimizes diagnosis of acute cholecystitis. ( Achong, DM; Chin, CT; Oates, E; Selland, DL, 1996) |
| "Morphine intervention in cholescintigraphy decreases imaging time to diagnose acute cholecystitis." | 3.69 | Morphine-augmented cholescintigraphy enhances duodenogastric reflux. ( Lee, JK; Magoun, S; Ryo, UY; Shih, WJ; Wierzbinski, B, 1995) |
| "When faced with a patient with possible acute cholecystitis, technetium-99m-HIDA scintigraphy should be the primary diagnostic procedure performed." | 3.66 | Diagnostic utility of cholescintigraphy and ultrasonography in acute cholecystitis. ( Burrell, MI; Cahow, CE; Caride, V; Zeman, RK, 1981) |
| "Ixazomib is an oral, second-generation, proteasome inhibitor that has been shown in preclinical models to prevent GVHD." | 2.94 | Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. ( Abedin, S; Chhabra, S; D'Souza, A; Dhakal, B; Douglas Rizzo, J; Drobyski, WR; Fenske, TS; Hamadani, M; Hari, PN; Horowitz, MM; Jerkins, JH; Pasquini, MC; Runaas, L; Saber, W; Shah, NN; Shaw, BE; Tang, X; Thompson, R; Visotcky, A; Zhang, MJ; Zhu, F, 2020) |
| "05), and there was no correlation between blood concentration and clinical characteristics such as age, gender, and dosage (P > ." | 1.91 | Correlation between blood concentration of roxadustat and clinical efficacy in patients with anemia of chronic kidney disease. ( Jing, Y; Zhang, Y; Zhou, C, 2023) |
| " The Morisky Medication Adherence Scale-8 (MMAS-8) was used to score medication compliance during rhEPO treatment and roxadustat treatment, and adverse reactions occurred during treatment were collected." | 1.72 | Long-term efficacy, safety, and medication compliance of roxadustat on peritoneal dialysis patients with renal anemia affected by the COVID-19 pandemic: a retrospective study. ( Bao, L; Bian, X; Huang, J; Luo, C; Ren, L; Zhang, A, 2022) |
| "We also reported an association of frailty and CWP caused by shared genetic and common environmental factors." | 1.48 | Multi-OMICS analyses of frailty and chronic widespread musculoskeletal pain suggest involvement of shared neurological pathways. ( Bell, JT; Bowyer, RCE; Livshits, G; Malkin, I; Menni, C; Steves, CJ; Verdi, S; Williams, FMK, 2018) |
| "Tinnitus was induced in rats using unilateral, 1 h, 17 kHz-centered octave-band noise (116 dB SPL) and assessed using a gap-startle method." | 1.35 | Plasticity at glycinergic synapses in dorsal cochlear nucleus of rats with behavioral evidence of tinnitus. ( Brozoski, TJ; Caspary, DM; Hughes, LF; Ling, L; Parrish, JL; Turner, JG; Wang, H, 2009) |
| "Glycine (GLY), which acts as an obligatory co-agonist at the NMDAR-GLY site, induces PPI deficits in rats although, consistent with the hypo-NMDAR hypothesis, improves negative and cognitive symptoms in schizophrenia patients." | 1.34 | High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. ( Bar, G; Ebstein, RP; Ermilov, M; Heresco-Levy, U; Javitt, DC; Levin, R, 2007) |
| "Afferent loop syndrome is caused by intermittent mechanical obstruction of the afferent loop of a gastrojejunostomy and may present early as an acute type or late as a chronic type." | 1.31 | Afferent loop syndrome: the role of Tc-99m mebrofenin hepatobiliary scintigraphy. ( Kumar, S; Muthukrishnan, A; Shanthly, N, 2000) |
| " In the healthy individuals, urinary guanidinoacetic acid excretion increased 5-fold by 2 h after dosing (15." | 1.28 | Clinical test of renal guanidinoacetic acid metabolism by oral citrulline and creatine loading. ( Kadono, K; Tetsutani, T; Yamaguchi, T; Yasunaga, K, 1992) |
| "Glycine was administered in an effort to facilitate endogenous glutamatergic transmission at the level of the N-methyl-D-aspartate (NMDA) receptor complex, since a glutamatergic deficiency in the pathophysiology of schizophrenia has been postulated." | 1.28 | Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study. ( Banay-Schwartz, M; Cohen, CG; Deutsch, SI; Leighton, M; Rosse, RB; Scarcella, E; Theut, SK, 1989) |
| " The patients with sprue had a significant reduction in the rate of absorption of glycine from a 20 mmol/1 solution, but there were no significant differences in the absorption of the other substances." | 1.26 | Intestinal perfusion studies in tropical sprue. 1. Amino acid and dipeptide absorption. ( Baker, SJ; Ganapathy, V; Hellier, MD; Mathan, VI; Radhakrishnan, AN, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (34.83) | 18.7374 |
| 1990's | 12 (13.48) | 18.2507 |
| 2000's | 21 (23.60) | 29.6817 |
| 2010's | 18 (20.22) | 24.3611 |
| 2020's | 7 (7.87) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, G | 1 |
| Zhao, M | 1 |
| Zhang, X | 1 |
| Peng, L | 1 |
| Li, C | 1 |
| Mao, W | 1 |
| Ye, W | 1 |
| Peng, S | 1 |
| Høyer, C | 1 |
| Christensen, MH | 1 |
| Sandermann, J | 1 |
| Leusink, R | 1 |
| Abrahamsen, J | 2 |
| Chen, T | 1 |
| Zhou, K | 1 |
| Sun, T | 1 |
| Sang, C | 1 |
| Jia, W | 1 |
| Xie, G | 1 |
| Bao, L | 1 |
| Bian, X | 1 |
| Zhang, A | 1 |
| Huang, J | 1 |
| Ren, L | 1 |
| Luo, C | 1 |
| Gao, T | 1 |
| Wang, R | 1 |
| Zhang, H | 1 |
| Zhao, F | 1 |
| Zhang, Y | 1 |
| Jing, Y | 1 |
| Zhou, C | 1 |
| Pidala, J | 1 |
| Bhatt, VR | 1 |
| Hamilton, B | 1 |
| Pusic, I | 1 |
| Wood, WA | 1 |
| Onstad, L | 1 |
| Hall, AM | 1 |
| Storer, B | 1 |
| Lee, SJ | 1 |
| Chhabra, S | 1 |
| Visotcky, A | 1 |
| Pasquini, MC | 1 |
| Zhu, F | 1 |
| Tang, X | 1 |
| Zhang, MJ | 1 |
| Thompson, R | 1 |
| Abedin, S | 1 |
| D'Souza, A | 1 |
| Dhakal, B | 1 |
| Drobyski, WR | 1 |
| Fenske, TS | 1 |
| Jerkins, JH | 1 |
| Douglas Rizzo, J | 1 |
| Runaas, L | 1 |
| Saber, W | 1 |
| Shah, NN | 1 |
| Shaw, BE | 1 |
| Horowitz, MM | 1 |
| Hari, PN | 1 |
| Hamadani, M | 1 |
| Livshits, G | 1 |
| Malkin, I | 1 |
| Bowyer, RCE | 1 |
| Verdi, S | 1 |
| Bell, JT | 1 |
| Menni, C | 1 |
| Williams, FMK | 1 |
| Steves, CJ | 1 |
| Pastor, CM | 1 |
| Akizawa, T | 1 |
| Iwasaki, M | 1 |
| Otsuka, T | 2 |
| Reusch, M | 1 |
| Misumi, T | 1 |
| Krylov, VN | 1 |
| Deriugina, AV | 1 |
| Antipenko, EA | 1 |
| Zakharova, OA | 1 |
| Zacho, HD | 2 |
| Sakai, M | 1 |
| Takenami, T | 1 |
| Hayashi, N | 1 |
| Yoshino, K | 1 |
| Matsumoto, S | 1 |
| Okamoto, H | 1 |
| Peng, GJ | 1 |
| Shi, BY | 1 |
| Tian, JS | 1 |
| Gao, S | 1 |
| Qin, XM | 1 |
| Calkins, KL | 1 |
| Sanchez, LA | 1 |
| Tseng, CH | 1 |
| Faull, KF | 1 |
| Yoon, AJ | 1 |
| Ryan, CM | 1 |
| Le, T | 1 |
| Shew, SB | 1 |
| Sierra-Paredes, G | 1 |
| Loureiro, AI | 1 |
| Wright, LC | 1 |
| Sierra-Marcuño, G | 1 |
| Soares-da-Silva, P | 1 |
| Santa Maria, PL | 1 |
| Kim, S | 1 |
| Varsak, YK | 1 |
| Yang, YP | 1 |
| Ganai, AA | 1 |
| Ganaie, IA | 1 |
| Verma, N | 1 |
| Farooqi, H | 1 |
| Couce, ML | 1 |
| Aldamiz-Echevarría, L | 1 |
| Bueno, MA | 1 |
| Barros, P | 1 |
| Belanger-Quintana, A | 1 |
| Blasco, J | 1 |
| García-Silva, MT | 1 |
| Márquez-Armenteros, AM | 1 |
| Vitoria, I | 1 |
| Vives, I | 1 |
| Navarrete, R | 1 |
| Fernández-Marmiesse, A | 1 |
| Pérez, B | 1 |
| Pérez-Cerdá, C | 1 |
| Garrido-Sanabria, ER | 1 |
| Otalora, LF | 1 |
| Arshadmansab, MF | 1 |
| Herrera, B | 1 |
| Francisco, S | 1 |
| Ermolinsky, BS | 1 |
| Rizos, EN | 1 |
| Siafakas, N | 1 |
| Katsantoni, E | 1 |
| Lazou, V | 1 |
| Sakellaropoulos, K | 1 |
| Kastania, A | 1 |
| Kossida, S | 1 |
| Chatzigeorgiou, KS | 1 |
| Arsenis, G | 1 |
| Zerva, L | 1 |
| Katsafouros, K | 1 |
| Lykouras, L | 1 |
| Potvin, S | 1 |
| Larouche, A | 1 |
| Normand, E | 1 |
| de Souza, JB | 1 |
| Gaumond, I | 1 |
| Grignon, S | 1 |
| Marchand, S | 1 |
| Wang, H | 1 |
| Brozoski, TJ | 1 |
| Turner, JG | 1 |
| Ling, L | 1 |
| Parrish, JL | 1 |
| Hughes, LF | 1 |
| Caspary, DM | 1 |
| MacLeod, BA | 1 |
| Wang, JT | 2 |
| Chung, CC | 1 |
| Ries, CR | 1 |
| Schwarz, SK | 1 |
| Puil, E | 1 |
| Maggio, G | 1 |
| Armenio, A | 1 |
| Ruccia, F | 1 |
| Giglietto, D | 1 |
| Pascone, M | 1 |
| Ribatti, D | 1 |
| Reismann, P | 1 |
| Eussen, SJ | 1 |
| Nilsen, RM | 1 |
| Midttun, Ø | 1 |
| Hustad, S | 1 |
| IJssennagger, N | 1 |
| Meyer, K | 1 |
| Fredriksen, Å | 1 |
| Ulvik, A | 1 |
| Ueland, PM | 1 |
| Brennan, P | 1 |
| Johansson, M | 1 |
| Bueno-de-Mesquita, B | 1 |
| Vineis, P | 1 |
| Chuang, SC | 1 |
| Boutron-Ruault, MC | 1 |
| Dossus, L | 1 |
| Perquier, F | 1 |
| Overvad, K | 1 |
| Teucher, B | 1 |
| Grote, VA | 1 |
| Trichopoulou, A | 1 |
| Adarakis, G | 1 |
| Plada, M | 1 |
| Sieri, S | 1 |
| Tumino, R | 1 |
| de Magistris, MS | 1 |
| Ros, MM | 1 |
| Peeters, PH | 1 |
| Redondo, ML | 1 |
| Zamora-Ros, R | 1 |
| Chirlaque, MD | 1 |
| Ardanaz, E | 1 |
| Sonestedt, E | 1 |
| Ericson, U | 1 |
| Schneede, J | 1 |
| van Guelpen, B | 1 |
| Wark, PA | 1 |
| Gallo, V | 1 |
| Norat, T | 1 |
| Riboli, E | 1 |
| Vollset, SE | 1 |
| Polgár, E | 1 |
| Hughes, DI | 1 |
| Riddell, JS | 1 |
| Maxwell, DJ | 1 |
| Puskár, Z | 1 |
| Todd, AJ | 1 |
| Miyazato, M | 1 |
| Sugaya, K | 1 |
| Nishijima, S | 1 |
| Ashitomi, K | 1 |
| Hatano, T | 1 |
| Ogawa, Y | 1 |
| BERLIN, NI | 1 |
| LAWRENCE, JH | 1 |
| LEE, HC | 1 |
| Canales, JJ | 1 |
| Elayadi, A | 1 |
| Errami, M | 1 |
| Llansola, M | 2 |
| Cauli, O | 2 |
| Felipo, V | 2 |
| Attman, PO | 1 |
| Ottosson, P | 1 |
| Samuelsson, O | 1 |
| Eriksson, UG | 1 |
| Eriksson-Lepkowska, M | 1 |
| Fager, G | 1 |
| Reid, SG | 1 |
| Powell, FL | 1 |
| Lu, VB | 1 |
| Moran, TD | 1 |
| Balasubramanyan, S | 1 |
| Alier, KA | 1 |
| Dryden, WF | 1 |
| Colmers, WF | 1 |
| Smith, PA | 1 |
| Heresco-Levy, U | 1 |
| Bar, G | 1 |
| Levin, R | 1 |
| Ermilov, M | 1 |
| Ebstein, RP | 1 |
| Javitt, DC | 1 |
| Tsang, SW | 1 |
| Vinters, HV | 1 |
| Cummings, JL | 1 |
| Wong, PT | 1 |
| Chen, CP | 1 |
| Lai, MK | 1 |
| Mlili, N | 1 |
| Berdeli, A | 1 |
| Emingil, G | 1 |
| Han Saygan, B | 1 |
| Gürkan, A | 1 |
| Atilla, G | 1 |
| Köse, T | 1 |
| Baylas, H | 1 |
| Nakamura, M | 1 |
| Ogura, T | 1 |
| Miyazawa, N | 1 |
| Tagawa, A | 1 |
| Kozawa, S | 1 |
| Watanuki, Y | 1 |
| Takahashi, H | 1 |
| Sato, H | 1 |
| Koike, Y | 1 |
| Honma, M | 1 |
| Yagame, M | 1 |
| Ito, K | 1 |
| Zeilhofer, HU | 1 |
| Zeman, RK | 1 |
| Burrell, MI | 1 |
| Cahow, CE | 1 |
| Caride, V | 1 |
| De Nicola, L | 1 |
| Peterson, OW | 1 |
| Obagi, S | 1 |
| Kaiser, JA | 1 |
| Wilson, CB | 1 |
| Gabbai, FB | 1 |
| Jensen, JC | 1 |
| Schaefer, R | 1 |
| Nwokedi, E | 1 |
| Bevans, DW | 1 |
| Baker, ML | 1 |
| Pappas, AA | 1 |
| Westbrook, KC | 1 |
| Klimberg, VS | 1 |
| Ishimaru, M | 1 |
| Kurumaji, A | 2 |
| Toru, M | 2 |
| Achong, DM | 2 |
| Oates, E | 2 |
| Matsunami, H | 1 |
| Lynch, SV | 1 |
| Balderson, GA | 1 |
| Strong, RW | 1 |
| Furuya, KN | 1 |
| Durie, PR | 1 |
| Roberts, EA | 1 |
| Soldin, SJ | 1 |
| Verjee, Z | 1 |
| Yung-Jato, L | 1 |
| Giesbrecht, E | 1 |
| Ellis, L | 1 |
| Selland, DL | 1 |
| Chin, CT | 1 |
| Shih, WJ | 1 |
| Lee, JK | 1 |
| Magoun, S | 1 |
| Wierzbinski, B | 1 |
| Ryo, UY | 1 |
| Watanabe, A | 1 |
| Kumashiro, S | 1 |
| Semba, J | 1 |
| Mishkind, MT | 1 |
| Pruitt, RF | 1 |
| Bambini, DA | 1 |
| Hakenewerth, AM | 1 |
| Thomason, MH | 1 |
| Zuger, JH | 1 |
| Novick, T | 1 |
| Yin, M | 1 |
| Rusyn, I | 1 |
| Schoonhoven, R | 1 |
| Graves, LM | 1 |
| Rusyn, EV | 1 |
| Li, X | 1 |
| Li, F | 1 |
| Cox, AD | 1 |
| Harding, TW | 1 |
| Bunzendahl, H | 1 |
| Swenberg, JA | 1 |
| Thurman, RG | 1 |
| Dolan, S | 1 |
| Nolan, AM | 1 |
| Muthukrishnan, A | 1 |
| Shanthly, N | 1 |
| Kumar, S | 1 |
| Mills, CD | 1 |
| Johnson, KM | 1 |
| Hulsebosch, CE | 1 |
| Tkaczewski, W | 1 |
| Chojnacki, J | 1 |
| Dziekański, S | 1 |
| Szeszko, A | 1 |
| Hellier, MD | 1 |
| Radhakrishnan, AN | 1 |
| Ganapathy, V | 1 |
| Mathan, VI | 1 |
| Baker, SJ | 1 |
| Hino, M | 1 |
| Nagatsu, T | 1 |
| Kakumu, S | 1 |
| Okuyama, S | 1 |
| Yoshii, Y | 1 |
| Nagatsu, I | 1 |
| Mel'k, MV | 1 |
| Shcheglova, SA | 1 |
| Volkova, ZA | 1 |
| Gundalakh, AI | 1 |
| Nikolov, N | 1 |
| Nedkov-Bratanova, N | 1 |
| Ivano, E | 1 |
| Kr"steva, A | 1 |
| Lozanova, L | 1 |
| Kadono, K | 1 |
| Yamaguchi, T | 1 |
| Tetsutani, T | 1 |
| Yasunaga, K | 1 |
| Costa, J | 1 |
| Khaled, E | 1 |
| Sramek, J | 1 |
| Bunney, W | 1 |
| Potkin, SG | 1 |
| Rosse, RB | 1 |
| Theut, SK | 1 |
| Banay-Schwartz, M | 1 |
| Leighton, M | 1 |
| Scarcella, E | 1 |
| Cohen, CG | 1 |
| Deutsch, SI | 1 |
| Korpi, ER | 1 |
| Kaufmann, CA | 1 |
| Marnela, KM | 1 |
| Weinberger, DR | 1 |
| Wolfson, M | 1 |
| Kopple, JD | 1 |
| Elsas, LJ | 1 |
| Naglak, M | 1 |
| Braga, PC | 1 |
| Bossi, R | 1 |
| Allegra, L | 1 |
| Okada, S | 1 |
| Hamada, K | 1 |
| Takasaki, N | 1 |
| Demura, A | 1 |
| Okano, H | 1 |
| Kirime, S | 1 |
| Noda, H | 1 |
| Ono, S | 1 |
| Akita, Y | 1 |
| Nishimoto, K | 1 |
| Matsumoto, K | 1 |
| Nagatake, T | 1 |
| Rikitomi, N | 1 |
| Uzuka, Y | 1 |
| Harada, T | 1 |
| Taguchi, M | 1 |
| Suzuki, H | 1 |
| Yoshimura, K | 1 |
| Chonabayashi, N | 1 |
| Nakatani, T | 1 |
| Nakamori, Y | 1 |
| Nakata, K | 1 |
| Tanimoto, H | 1 |
| Cook, GC | 1 |
| Barton, AD | 1 |
| Powers, JL | 1 |
| Lourenco, RV | 1 |
| Dotchev, D | 1 |
| Hungerland, H | 1 |
| Liappis, N | 1 |
| Oyanagi, K | 1 |
| Riede, UN | 1 |
| Zollinger, HU | 1 |
| Mihatsch, MJ | 1 |
| Colombi, A | 1 |
| Villinger, W | 1 |
| Smagin, VG | 1 |
| Asafov, GB | 1 |
| Ekisenina, NI | 1 |
| Ivanova, LM | 1 |
| Lumel'skiĭ, VIa | 1 |
| Labò, G | 1 |
| Barbara, L | 1 |
| Gasbarrini, G | 1 |
| Roda, E | 1 |
| Schiavina, M | 1 |
| Bonvicini, F | 1 |
| Pedersen, L | 1 |
| Arnfred, T | 1 |
| Thaysen, EH | 1 |
| Antun, FT | 1 |
| Burnett, GB | 1 |
| Cooper, AJ | 1 |
| Daly, RJ | 1 |
| Smythies, JR | 1 |
| Zealley, AK | 1 |
| Neitz, WO | 1 |
| McCully, M | 1 |
| Lapinski, EM | 1 |
| Flakas, ED | 1 |
| Walls, WD | 1 |
| Losowsky, MS | 1 |
| Samson, EI | 1 |
| Mestyán, J | 1 |
| Fekete, M | 1 |
| Soltész, G | 1 |
| Járai, I | 1 |
| Gáti, I | 1 |
| Preisz, J | 1 |
| Doszpod, J | 1 |
| Campanacci, L | 1 |
| Guarnieri, GF | 1 |
| Siliprandi, N | 1 |
| Fiaschi, E | 1 |
| Iwanow, ED | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation[NCT02250300] | Phase 1/Phase 2 | 68 participants (Actual) | Interventional | 2014-11-19 | Completed | ||
| ASP1517 Phase 2 Clinical Trial -A Multi-center, Randomized, Parallel Groups, Placebo-controlled, Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-[NCT01964196] | Phase 2 | 107 participants (Actual) | Interventional | 2013-09-17 | Completed | ||
| A Trial of the Effects of Glycine Loading on Clinical Symptoms and Logical Memory in Patients With Schizophrenia[NCT00575848] | Phase 1 | 16 participants (Anticipated) | Interventional | 2007-12-31 | Terminated (stopped due to Slow enrollment and due to personnel change there was no viable way to quantify glycine levels through imaging) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The number of participants who have graft-versus-host disease. The two expansion phase cohorts (3.0 mg and 4.0 mg) were not included in this analysis. (NCT02250300)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| MLN9708 Phase II Matched Sibling | 9 |
| MLN9708 Phase II Matched Unrelated | 10 |
Maximum-tolerated dose of ixazomib (MLN9708) will be determined from the incidence of dose limiting toxicities at each dosage. Results for both escalation phase cohorts (3.0 mg and 4.0 mg) were used to determine the maximum tolerated dose. (NCT02250300)
Timeframe: 4 weeks
| Intervention | millligram (Number) |
|---|---|
| Maximum Tolerated Dose of Study Drug | 4 |
A 3+3 design will be employed. At each dose, three patients will be initially evaluated. If no dose limiting toxicities are observed, the MLN9708 dose will be increased; if one dose limiting toxicity is observed, three additional patients will be treated at that dose. A dose at which two DLTs are observed in three or six patients are judged to be too toxic, the lower dose will be defined as the maximally tolerated dose (MTD). (NCT02250300)
Timeframe: 4 weeks
| Intervention | dose limiting toxicity (Number) |
|---|---|
| MLN9708 Phase I (3.0 mg) | 0 |
| MLN9708 Phase I (4.0 mg) | 0 |
2 reviews available for glycine and Chronic Disease
| Article | Year |
|---|---|
Chronic intestinal ischaemia: measurement of the total splanchnic blood flow.
Topics: Angiography; Aniline Compounds; Animals; Anthropometry; Chronic Disease; Fasting; Glycine; Humans; I | 2013 |
Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microglia.
Topics: Animals; Chronic Disease; Dinoprostone; gamma-Aminobutyric Acid; Glycine; Humans; Inflammation; Micr | 2008 |
13 trials available for glycine and Chronic Disease
| Article | Year |
|---|---|
Chronic mesenteric ischaemia: the importance of the individual mesenteric artery.
Topics: Aniline Compounds; Chronic Disease; Glycine; Humans; Mesenteric Arteries; Mesenteric Ischemia; Oxyge | 2022 |
Ixazomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Phase II Trial.
Topics: Boron Compounds; Chronic Disease; Glycine; Graft vs Host Disease; Hematopoietic Stem Cell Transplant | 2020 |
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
Topics: Boron Compounds; Chronic Disease; Glycine; Graft vs Host Disease; Hematopoietic Stem Cell Transplant | 2020 |
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Aged; Anemia; Chronic Disease; Double-Blind Method; Female; Glycine; Humans; Isoquinolines; J | 2019 |
Effect of High-Dose Cysteine Supplementation on Erythrocyte Glutathione: A Double-Blinded, Randomized Placebo-Controlled Pilot Study in Critically Ill Neonates.
Topics: Amino Acids; Chronic Disease; Critical Illness; Cysteine; Dietary Supplements; Dose-Response Relatio | 2016 |
Functional versus radiological assessment of chronic intestinal ischaemia.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Aniline Compounds; Blood Flow Velocity; Chronic Disease | 2010 |
A new protocol for the treatment of the chronic venous ulcers of the lower limb.
Topics: Administration, Topical; Adolescent; Adult; Aged; Alginates; Cellulose; Chronic Disease; Compression | 2012 |
Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Azetidines; Benzylamines; Chronic Disease; Dalteparin; G | 2005 |
[A double-blind study of strong neominophagen-C in treating chronic hepatitis].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Cysteine; Double-Blind Method; Drug Combinations; | 1984 |
Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
Topics: Adult; Aged; Bronchitis; Chronic Disease; Double-Blind Method; Elasticity; Expectorants; Glycine; Hu | 1987 |
[Clinical application of PPC for nonspecific chronic prostatitis].
Topics: Alanine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Glutamin | 1985 |
[ -Mercaptopropionylglycine (Thiola) in the treatment of chronic hepatitis].
Topics: Adolescent; Adult; Aged; Azathioprine; Chronic Disease; Clinical Trials as Topic; Drug Tolerance; Ev | 1972 |
The effects of L-methionine (without MAOI) in schizophrenia.
Topics: Catechols; Chronic Disease; Clinical Trials as Topic; Female; Fluorometry; Glycine; Glycols; Humans; | 1971 |
74 other studies available for glycine and Chronic Disease
| Article | Year |
|---|---|
A class of novel conjugates of substituted purine and Gly-AA-OBzl: synthesis and evaluation of orally analgesic activity.
Topics: Administration, Oral; Analgesics; Animals; Chronic Disease; Glycine; Humans; Male; Mice; Pain; Purin | 2010 |
Altered bile acid glycine : taurine ratio in the progression of chronic liver disease.
Topics: Bile Acids and Salts; Case-Control Studies; Chronic Disease; Disease Progression; Female; Glycine; H | 2022 |
Long-term efficacy, safety, and medication compliance of roxadustat on peritoneal dialysis patients with renal anemia affected by the COVID-19 pandemic: a retrospective study.
Topics: Anemia; Chronic Disease; COVID-19; Glycine; Humans; Iron; Isoquinolines; Medication Adherence; Pande | 2022 |
Network pharmacology combined with metabolomics reveals the mechanism of Fuzi decoction against chronic heart failure in rats.
Topics: Animals; beta-Alanine; Chronic Disease; Coenzyme A; Diterpenes; Drugs, Chinese Herbal; Glycine; Glyo | 2022 |
Correlation between blood concentration of roxadustat and clinical efficacy in patients with anemia of chronic kidney disease.
Topics: Anemia; Chronic Disease; Glycine; Humans; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolin | 2023 |
Multi-OMICS analyses of frailty and chronic widespread musculoskeletal pain suggest involvement of shared neurological pathways.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Chronic Disease; Computational Biology; Epigenomics | 2018 |
Isolated Perfused Rat Livers to Quantify the Pharmacokinetics and Concentrations of Gd-BOPTA.
Topics: Aniline Compounds; Animals; ATP-Binding Cassette Transporters; Bile Canaliculi; Biological Transport | 2018 |
[The diagnostics of adaptive reactions of blood on application the stress-modulating therapy in patients with brain chronic ischemia].
Topics: Adult; Brain Ischemia; Chronic Disease; Delta Sleep-Inducing Peptide; Drug Combinations; Erythrocyte | 2012 |
[Anesthetic management of posterior lumbar spinal fusion in a patient suspected of having acute exacerbation of chronic interstitial pneumonia].
Topics: Acute-Phase Reaction; Aged; Airway Management; Anesthesia; Chronic Disease; Disease Progression; Eme | 2014 |
[1H NMR based metabonomics study on the antidepressant effect of genipin in rat hippocampus].
Topics: Alanine; Animals; Antidepressive Agents; Aspartic Acid; Behavior, Animal; Chronic Disease; Depressio | 2014 |
Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus.
Topics: Acute Disease; Amino Acids; Animals; Anticonvulsants; Aspartic Acid; Bridged Bicyclo Compounds, Hete | 2014 |
Heparin binding-epidermal growth factor-like growth factor for the regeneration of chronic tympanic membrane perforations in mice.
Topics: Animals; Biocompatible Materials; Chronic Disease; Disease Models, Animal; Drug Delivery Systems; Er | 2015 |
Regression of fibrosis/cirrhosis by Glycine propionyl-l-carnitine treatment in d-Galactosamine induced chronic liver damage.
Topics: Actins; Animals; Body Weight; Carnitine; Chronic Disease; Collagen Type I; Galactosamine; Gene Expre | 2016 |
Genotype and phenotype characterization in a Spanish cohort with isovaleric acidemia.
Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Asymptomatic Diseases; Carnitine; Child; Child, | 2017 |
Impaired expression and function of group II metabotropic glutamate receptors in pilocarpine-treated chronically epileptic rats.
Topics: Animals; Anticonvulsants; Blotting, Western; Brain; Chronic Disease; Convulsants; Cyclopropanes; Epi | 2008 |
Association of the dopamine D3 receptor Ser9Gly and of the serotonin 2C receptor gene polymorphisms with tardive dyskinesia in Greeks with chronic schizophrenic disorder.
Topics: Amino Acid Substitution; Chronic Disease; Dyskinesias; Female; Genetic Predisposition to Disease; Gl | 2009 |
DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls.
Topics: Adult; Amino Acid Sequence; Chronic Disease; DNA Mutational Analysis; Dopamine; Female; Fibromyalgia | 2009 |
Plasticity at glycinergic synapses in dorsal cochlear nucleus of rats with behavioral evidence of tinnitus.
Topics: Acoustic Stimulation; Animals; Carrier Proteins; Chronic Disease; Cochlear Nucleus; Evoked Potential | 2009 |
Analgesic properties of the novel amino acid, isovaline.
Topics: Acute Disease; Analgesics, Non-Narcotic; Animals; beta-Alanine; Chronic Disease; Cisterna Magna; Fem | 2010 |
[Study of the Toll-like receptor 4 gene polymorphisms in diseases presenting with subclinical and chronic inflammation].
Topics: Alleles; Aspartic Acid; Brain Ischemia; Chronic Disease; Cytokines; Diabetes Complications; Diabetic | 2011 |
North-south gradients in plasma concentrations of B-vitamins and other components of one-carbon metabolism in Western Europe: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
Topics: Adult; Aged; Alcohol Drinking; Chronic Disease; Ethnicity; Europe; Female; Folic Acid; Glycine; Heal | 2013 |
Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain.
Topics: Animals; Chronic Disease; gamma-Aminobutyric Acid; Glycine; Hot Temperature; Hyperalgesia; Male; Pai | 2003 |
Inhibitory effect of intrathecal glycine on the micturition reflex in normal and spinal cord injury rats.
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Female; Glutamic Acid; Glycine; Gly | 2003 |
The pathogenesis of the anemia of chronic leukemia; measurement of the life span of the red blood cell with glycine-2-C14.
Topics: Anemia; Chronic Disease; Erythrocytes; Glycine; Humans; Leukemia | 1954 |
Chronic hyperammonemia alters motor and neurochemical responses to activation of group I metabotropic glutamate receptors in the nucleus accumbens in rats in vivo.
Topics: Animals; Chromones; Chronic Disease; Dopamine; Excitatory Amino Acid Agonists; Excitatory Amino Acid | 2003 |
Effects of chronic hypoxia on MK-801-induced changes in the acute hypoxic ventilatory response.
Topics: Acetamides; Adaptation, Physiological; Animals; Chronic Disease; Dizocilpine Maleate; Glycine; Hypox | 2005 |
Substantia Gelatinosa neurons in defined-medium organotypic slice culture are similar to those in acute slices from young adult rats.
Topics: Action Potentials; Afferent Pathways; Aging; Animals; Chronic Disease; Culture Media; Electric Stimu | 2006 |
High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients.
Topics: Adult; Blinking; Chronic Disease; Electromyography; Female; Glutamic Acid; Glycine; Humans; Inhibiti | 2007 |
Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anxiety Disorders; Binding, Competitive; Brain; Chronic | 2008 |
Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats.
Topics: Animals; Behavior, Animal; Brain; Chronic Disease; Dopamine; Excitatory Amino Acid Agonists; Excitat | 2007 |
TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population.
Topics: Adult; Aged; Alleles; Arginine; Aspartic Acid; Case-Control Studies; Chronic Disease; Dental Plaque; | 2007 |
[Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
Topics: Acute Disease; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers; Chronic Disease; Disease Pro | 2007 |
Evaluation of thyroid hormone action in a case of generalized resistance to thyroid hormone with chronic thyroiditis: discovery of a novel heterozygous missense mutation (G347A).
Topics: Adult; Alanine; Base Sequence; Chronic Disease; DNA Mutational Analysis; Female; Glycine; Heterozygo | 2007 |
Diagnostic utility of cholescintigraphy and ultrasonography in acute cholecystitis.
Topics: Acute Disease; Adult; Aged; Chemical Phenomena; Chemistry; Cholecystitis; Cholelithiasis; Chronic Di | 1981 |
Renal functional reserve in experimental chronic glomerulonephritis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies; Antihypertensive Agents; Basement Mem | 1994 |
Prevention of chronic radiation enteropathy by dietary glutamine.
Topics: Administration, Oral; Animals; Chronic Disease; Glutamine; Glutathione; Glycine; Intestinal Diseases | 1994 |
Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis.
Topics: Adult; Aged; Brain Mapping; Cerebral Cortex; Chronic Disease; Female; Glutamates; Glutamic Acid; Gly | 1994 |
A reversed sequence of gallbladder and small bowel visualization during cholescintigraphy. Its relationship to chronic cholecystitis.
Topics: Aniline Compounds; Bile; Cholecystitis; Chronic Disease; Female; Gallbladder; Glycine; Humans; Imino | 1994 |
Use of glycyrrhizin for recurrence of hepatitis B after liver transplantation.
Topics: Chronic Disease; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhiza; Hepatitis B; Humans; Liv | 1993 |
Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function.
Topics: 4-Aminobenzoic Acid; Acute Disease; Adolescent; Aminohippuric Acids; Child; Child, Preschool; Chroni | 1995 |
Gallbladder nonvisualization with pericholecystic rim sign: morphine-augmentation optimizes diagnosis of acute cholecystitis.
Topics: Acute Disease; Aniline Compounds; Case-Control Studies; Cholecystitis; Chronic Disease; False Positi | 1996 |
Morphine-augmented cholescintigraphy enhances duodenogastric reflux.
Topics: Acute Disease; Aniline Compounds; Cholecystitis; Chronic Disease; Duodenogastric Reflux; Evaluation | 1995 |
A postmortem study of glycine and its potential precursors in chronic schizophrenics.
Topics: Adult; Aged; Brain Chemistry; Chromatography, High Pressure Liquid; Chronic Disease; Female; Glycine | 1996 |
Effectiveness of cholecystokinin-stimulated cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease.
Topics: Adult; Aniline Compounds; Case-Control Studies; Cholecystectomy; Cholecystitis; Chronic Disease; Fem | 1997 |
Inhibition of chronic rejection of aortic allografts by dietary glycine.
Topics: Animals; Aorta; Aorta, Abdominal; Cell Count; Cell Division; Cell Movement; Cells, Cultured; Chronic | 2000 |
Behavioural evidence supporting a differential role for group I and II metabotropic glutamate receptors in spinal nociceptive transmission.
Topics: Amino Acids, Dicarboxylic; Animals; Behavior, Animal; Chronic Disease; Cycloleucine; Excitatory Amin | 2000 |
Afferent loop syndrome: the role of Tc-99m mebrofenin hepatobiliary scintigraphy.
Topics: Adult; Afferent Loop Syndrome; Aged; Aniline Compounds; Barium Sulfate; Bile Ducts, Intrahepatic; Ch | 2000 |
Group I metabotropic glutamate receptors in spinal cord injury: roles in neuroprotection and the development of chronic central pain.
Topics: Animals; Benzoates; Chronic Disease; Excitatory Amino Acid Antagonists; Glycine; Hyperalgesia; Locom | 2002 |
[Combined administration of metoclopramide, scopolan and proacid in the treatment of chronic duodenal ulcer].
Topics: Adult; Aluminum; Aluminum Hydroxide; Butylscopolammonium Bromide; Chronic Disease; Drug Therapy, Com | 1978 |
Intestinal perfusion studies in tropical sprue. 1. Amino acid and dipeptide absorption.
Topics: Amino Acids; Chronic Disease; Dipeptidases; Dipeptides; Glycine; Glycylglycine; Humans; Intestinal A | 1976 |
Glycylprolyl beta-naphthylamidase activity in human serum.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferas | 1975 |
[Some indices of nitrogen metabolism in patients with viral hepatitis].
Topics: Adolescent; Adult; Alanine; Ammonia; Asparagine; Chronic Disease; Cysteine; Cystinuria; Glutamates; | 1975 |
[Dipeptidase activity in the small intestine of patients with chronic nonspecific enteritis].
Topics: Adult; Alanine; Chronic Disease; Dipeptidases; Dipeptides; Enteritis; Female; Glutamates; Glycine; H | 1975 |
Clinical test of renal guanidinoacetic acid metabolism by oral citrulline and creatine loading.
Topics: 17-Ketosteroids; Amidinotransferases; Animals; Chronic Disease; Citrulline; Creatine; Diabetes Melli | 1992 |
An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Glycine; Humans; Male; Psychiatric | 1990 |
Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Basal Ganglia Diseases; Benztropine; Chronic Disease; Cognitio | 1989 |
Cerebrospinal fluid amino acid concentrations in chronic schizophrenia.
Topics: Adult; Aged; Alanine; Amino Acids; Chronic Disease; Female; Glutamates; Glutamic Acid; Glutamine; Gl | 1987 |
The effects of vitamin B-6 deficiency in chronically azotemic and sham-operated rats.
Topics: Alanine; Animals; Asparagine; Aspartate Aminotransferases; Chronic Disease; Creatinine; Erythrocytes | 1987 |
Acute and chronic-intermittent isovaleric acidemia: diagnosis and glycine therapy.
Topics: Acute Disease; Child; Child, Preschool; Chronic Disease; Female; Glycine; Hemiterpenes; Humans; Isov | 1988 |
[Clinical trial of a new immunomodulator, forphenicinol, against chronic respiratory infections].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Chronic Disease; Female; Glycine; Humans; Macrophag | 1985 |
[Clinical and immunological studies on forphenicinol, a low molecular weight immunomodulator, in chronic respiratory infections].
Topics: Adjuvants, Immunologic; Adult; Aged; Bronchiectasis; Bronchitis; Chronic Disease; Female; Glycine; H | 1985 |
Increased glycine absorption rate associated with acute bacterial infections in man.
Topics: Acute Disease; Adult; Chronic Disease; gamma-Globulins; Glycine; Hemoglobinometry; Humans; Intestina | 1973 |
Gamma glutamyl transpeptidase in chronic obstructive pulmonary disease.
Topics: Bronchitis; Chromatography, Thin Layer; Chronic Disease; Dipeptides; DNA; Esters; gamma-Glutamyltran | 1974 |
[Hyperiminoaciduria and disaminoaciduria in endemic (Balkan-)nephropathy (author's transl)].
Topics: Adult; Aged; Alanine; Amino Acids; Chromatography, Thin Layer; Chronic Disease; Creatinine; Female; | 1974 |
Case report of a familial oxalosis (ultrastructural study on the pathogenesis of kidney changes).
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Basement Membrane; Biopsy; Chronic Disease; Crystalliza | 1973 |
[Amino acid levels in the blood serum of patients with chronic colitis].
Topics: Adult; Alanine; Amino Acids; Ammonia; Arginine; Aspartic Acid; Betaine; Chronic Disease; Citrulline; | 1974 |
Rapid screening of increased bile acid deconjugation and bile acid malabsorption by means of the glycine-l-(14C) cholylglycine assay.
Topics: Achlorhydria; Adult; Aged; Bile Acids and Salts; Carbon Radioisotopes; Chronic Disease; Colitis; Cro | 1973 |
Clinicopathological study on experimental Trypanosoma brucei infections in horses. 1. Development of clinically recognizable nervous symptoms in nagana-infected horses treated with subcurative doses of Antrypol and Berenil.
Topics: Acetates; Amidines; Animals; Azo Compounds; Brain; Chronic Disease; Glycine; Horse Diseases; Horses; | 1971 |
Induction of L forms of Haemophilus influenzae in culture and their demonstration in human bronchial secretions.
Topics: Bronchitis; Chronic Disease; Fluorescent Antibody Technique; Glycine; Haemophilus influenzae; In Vit | 1967 |
Abnormalities of fibrin stabilization in liver and kidney disease: a comparison of two different methods.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Chronic Disease; Factor XIII; Female; Glycine; Hemorrh | 1969 |
[Alterations of pH and pressure in the stomach in patients with chronic gastritis and duodenal ulcer (radiotelemetric date)].
Topics: Adult; Bicarbonates; Chronic Disease; Duodenal Ulcer; Female; Gastritis; Glycine; Humans; Hydrogen-I | 1969 |
The postnatal changes in the circulating free amino acid pool in the newborn infant. 3. The plasma amino acid ratio in infants born after pregnancies complicated by toxaemia, placental infarction, impaired umbilical circulation and chronic maternal diseas
Topics: Amino Acids; Chronic Disease; Female; Glutamine; Glycine; Heart Defects, Congenital; Heart Failure; | 1971 |
Metabolic studies of acetoacetate, pyruvate, lactate and citrate in uremic acidosis.
Topics: Acetoacetates; Acidosis; Analysis of Variance; Chronic Disease; Citrates; Citric Acid Cycle; Creatin | 1968 |
[Porphyrin metabolism in endemic nephropathy and in persons in danger of lead poisoning].
Topics: Bulgaria; Chronic Disease; Erythrocytes; Female; Glycine; Hematocrit; Humans; Iron; Kidney Diseases; | 1968 |